A closer look at the technologies used by The Dolomite Centre
The Dolomite Centre
Business Services · United Kingdom · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Anglian Business Park, Orchard Road Unit...Phone Number
+44 1763242491Revenue
$19.7 MillionIndustry
About The Dolomite Centre
Dolomite Microfluidics specializes in microfluidics-based solutions for various applications, including drug encapsulation, droplet manufacture, and particle generation. They offer a range of application-specific systems, components, and custom devices tailored to meet client needs. Their products cater to sectors such as biologics, gene therapy, cell therapy, and nanoparticle production. The company aims to enhance research and development processes through innovative technology and automation.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to The Dolomite Centre
Compare insights from companies similar to The Dolomite Centre, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
The Dolomite Centre
$19.7M
51-200
Private
-
2005
N/A
The Dolomite Centre Tech Stack
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding The Dolomite Centre
Sign Up For FreeTo access detailed company insights
Dolomite Microfluidics specializes in microfluidics-based solutions for various applications, including drug encapsulation, droplet manufacture, and particle generation. They offer a range of application-specific systems, components, and custom devices tailored to meet client needs. Their products cater to sectors such as biologics, gene therapy, c... Read More
